If you are still having problems viewing this message, please click here for additional help.

Neuropsychopharmacology
 
TABLE OF CONTENTS

Volume 43, Issue 9

In this issue
Correspondence
Response
Research Highlight
Article
In Memoriam
Also new
AOP
 

Correspondence

The need for precise answers for the goals of precision medicine in alcohol dependence to succeed

Daniel E. Bradford, Gaylen E. Fronk, Sarah J. Sant'Ana, Katherine P. Magruder, Jesse T. Kaye et al.

Neuropsychopharmacology 2018 43 :1799 - 1800; June 12, 2018; 10.1038/s41386-018-0112-y

 

Abstract | Full Text

Response

Response to Letter to Editor (Precision medicine in alcohol dependence: evidence of efficacy and initial support for comparative effectiveness)

Karl Mann, Corey R Roos & Katie Witkiewitz

Neuropsychopharmacology 2018 43 :1801 - 1802; June 12, 2018; 10.1038/s41386-018-0113-x

 

Abstract | Full Text

Research Highlight

Kappa-opioid antagonists as stress resilience medications for the treatment of alcohol use disorders

Charles Chavkin

Neuropsychopharmacology 2018 43 :1803 - 1804; March 27, 2018; 10.1038/s41386-018-0046-4

 

Abstract | Full Text

Article

Preclinical evaluation of the kappa-opioid receptor antagonist CERC-501 as a candidate therapeutic for alcohol use disorders

E Domi, E Barbier, E Augier, G Augier, D Gehlert et al.

Neuropsychopharmacology 2018 43 :1805 - 1812; February 05, 2018; 10.1038/s41386-018-0015-y

 

Abstract | Full Text

Prophylactic ketamine alters nucleotide and neurotransmitter metabolism in brain and plasma following stress

Josephine C. McGowan, Collin Hill, Alessia Mastrodonato, Christina T. LaGamma, Alexander Kitayev et al.

Neuropsychopharmacology 2018 43 :1813 - 1821; March 29, 2018; 10.1038/s41386-018-0043-7

 

Abstract | Full Text

Cortical inhibitory markers of lifetime suicidal behavior in depressed adolescents

Charles P. Lewis, Paul A. Nakonezny, Caren J. Blacker, Jennifer L. Vande Voort, John D. Port et al.

Neuropsychopharmacology 2018 43 :1822 - 1831; March 14, 2018; 10.1038/s41386-018-0040-x

 

Abstract | Full Text

Influence of alcoholism and cholesterol on TSPO binding in brain: PET [11C]PBR28 studies in humans and rodents

Sung Won Kim, Corinde E. Wiers, Ryan Tyler, Ehsan Shokri-Kojori, Yeon Joo Jang et al.

Neuropsychopharmacology 2018 43 :1832 - 1839; May 03, 2018; 10.1038/s41386-018-0085-x

 

Abstract | Full Text

Deficient endocannabinoid signaling in the central amygdala contributes to alcohol dependence-related anxiety-like behavior and excessive alcohol intake

Antonia Serrano, Francisco J. Pavon, Matthew W. Buczynski, Joel Schlosburg, Luis A. Natividad et al.

Neuropsychopharmacology 2018 43 :1840 - 1850; April 05, 2018; 10.1038/s41386-018-0055-3

 

Abstract | Full Text

Deficient inhibition in alcohol-dependence: let's consider the role of the motor system!

Caroline Quoilin, Emmanuelle Wilhelm, Pierre Maurage, Philippe de Timary & Julie Duque

Neuropsychopharmacology 2018 43 :1851 - 1858; April 26, 2018; 10.1038/s41386-018-0074-0

 

Abstract | Full Text

Effects of alcohol dependence on discrete choice between alcohol and saccharin

Melissa Russo, Douglas Funk, Andrew Loughlin, Kathleen Coen & A. D. Lê

Neuropsychopharmacology 2018 43 :1859 - 1866; May 22, 2018; 10.1038/s41386-018-0101-1

 

Abstract | Full Text

Small molecule modulators of σ2R/Tmem97 reduce alcohol withdrawal-induced behaviors

Luisa L. Scott, James J. Sahn, Antonio Ferragud, Rachel C. Yen, Praveen N. Satarasinghe et al.

Neuropsychopharmacology 2018 43 :1867 - 1875; April 20, 2018; 10.1038/s41386-018-0067-z

 

Abstract | Full Text

Cerebral white matter sex dimorphism in alcoholism: a diffusion tensor imaging study

Kayle S. Sawyer, Nasim Maleki, George Papadimitriou, Nikos Makris, Marlene Oscar-Berman et al.

Neuropsychopharmacology 2018 43 :1876 - 1883; May 09, 2018; 10.1038/s41386-018-0089-6

 

Abstract | Full Text

Ventral striatal response during decision making involving risk and reward is associated with future binge drinking in adolescents

Angelica M. Morales, Scott A. Jones, Alissa Ehlers, Jessye B. Lavine & Bonnie J. Nagel

Neuropsychopharmacology 2018 43 :1884 - 1890; May 07, 2018; 10.1038/s41386-018-0087-8

 

Abstract | Full Text

Differences in the subjective and motivational properties of alcohol across alcohol use severity: application of a novel translational human laboratory paradigm

Spencer Bujarski, J. David Jentsch, Daniel J. O. Roche, Vijay A. Ramchandani, Karen Miotto et al.

Neuropsychopharmacology 2018 43 :1891 - 1899; May 08, 2018; 10.1038/s41386-018-0086-9

 

Abstract | Full Text

(2R,6R)-Hydroxynorketamine is not essential for the antidepressant actions of (R)-ketamine in mice

Jun-ichi Yamaguchi, Hidetoh Toki, Youge Qu, Chun Yang, Hiroyuki Koike et al.

Neuropsychopharmacology 2018 43 :1900 - 1907; May 03, 2018; 10.1038/s41386-018-0084-y

 

Abstract | Full Text

7T 1H-MRS in major depressive disorder: a Ketamine Treatment Study

Jennifer W. Evans, Níall Lally, Li An, Ningzhi Li, Allison C. Nugent et al.

Neuropsychopharmacology 2018 43 :1908 - 1914; April 05, 2018; 10.1038/s41386-018-0057-1

 

Abstract | Full Text

Ketamine administration during a critical period after forced ethanol abstinence inhibits the development of time-dependent affective disturbances

Oliver Vranjkovic, Garrett Winkler & Danny G. Winder

Neuropsychopharmacology 2018 43 :1915 - 1923; May 24, 2018; 10.1038/s41386-018-0102-0

 

Abstract | Full Text

Repeated social defeat-induced neuroinflammation, anxiety-like behavior and resistance to fear extinction were attenuated by the cannabinoid receptor agonist WIN55,212-2

Sabrina Francesca Lisboa, Anzela Niraula, Leonardo Barbosa Resstel, Francisco Silveira Guimaraes, Jonathan P. Godbout et al.

Neuropsychopharmacology 2018 43 :1924 - 1933; April 17, 2018; 10.1038/s41386-018-0064-2

 

Abstract | Full Text

Voluntary wheel running promotes resilience to chronic social defeat stress in mice: a role for nucleus accumbens ΔFosB

Joram D. Mul, Marion Soto, Michael E. Cahill, Rebecca E. Ryan, Hirokazu Takahashi et al.

Neuropsychopharmacology 2018 43 :1934 - 1942; May 24, 2018; 10.1038/s41386-018-0103-z

 

Abstract | Full Text

NPTX2 is a key component in the regulation of anxiety

Simon Chang, Philane Bok, Ching-Yen Tsai, Cheng-Pu Sun, Hsuan Liu et al.

Neuropsychopharmacology 2018 43 :1943 - 1953; May 11, 2018; 10.1038/s41386-018-0091-z

 

Abstract | Full Text

At-risk individuals display altered brain activity following stress

J. M. C. van Leeuwen, M. Vink, G. Fernández, E. J. Hermans, M. Joëls et al.

Neuropsychopharmacology 2018 43 :1954 - 1960; February 26, 2018; 10.1038/s41386-018-0026-8

 

Abstract | Full Text

Profiling changes in cortical astroglial cells following chronic stress

Stephanie Simard, Gianfilippo Coppola, Christopher A. Rudyk, Shawn Hayley, Robyn J. McQuaid et al.

Neuropsychopharmacology 2018 43 :1961 - 1971; May 29, 2018; 10.1038/s41386-018-0105-x

 

Abstract | Full Text

Aberrant working memory processing in major depression: evidence from multivoxel pattern classification

Matti Gärtner, M. Elisabetta Ghisu, Milan Scheidegger, Luisa Bönke, Yan Fan et al.

Neuropsychopharmacology 2018 43 :1972 - 1979; May 02, 2018; 10.1038/s41386-018-0081-1

 

Abstract | Full Text

In Memoriam

In Memoriam—Dr. Baron Avery Shopsin

Samuel Gershon

Neuropsychopharmacology 2018 43 :1980 - 1980; May 17, 2018; 10.1038/s41386-018-0060-6

 

Abstract | Full Text

Advertisement
Nature Briefing is an essential round-up of science news, opinion and analysis, free in your inbox every weekday. With Nature Briefing, we'll keep you updated on the latest research, so you can focus on yours.

Click here to sign up.
nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Neuropsychopharmacology.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2018 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.

Springer Nature